MARKET

GOSS

GOSS

Gossamer Bio
NASDAQ
1.270
0.000
0.00%
Opening 12:36 02/27 EST
OPEN
1.280
PREV CLOSE
1.270
HIGH
1.330
LOW
1.209
VOLUME
239.14K
TURNOVER
0
52 WEEK HIGH
1.910
52 WEEK LOW
0.4525
MARKET CAP
286.27M
P/E (TTM)
-0.7209
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at GOSS last week (0219-0223)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Monopar Therapeutics shares rose 138.8% to $0.82 during Tuesday's regular session. Trxade Health (NASDAQ:MEDS) shares rose 86.05% in the same session. RAPT Therapeutic and other companies reported their fourth quarter earnings today.
Benzinga · 02/20 17:31
Weekly Report: what happened at GOSS last week (0212-0216)?
Weekly Report · 02/19 09:28
Weekly Report: what happened at GOSS last week (0205-0209)?
Weekly Report · 02/12 09:25
Weekly Report: what happened at GOSS last week (0129-0202)?
Weekly Report · 02/05 09:27
Weekly Report: what happened at GOSS last week (0122-0126)?
Weekly Report · 01/29 09:25
Weekly Report: what happened at GOSS last week (0115-0119)?
Weekly Report · 01/22 09:26
Weekly Report: what happened at GOSS last week (0108-0112)?
Weekly Report · 01/15 09:26
More
About GOSS
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its product candidates include Seralutinib (GB002), GB5121 and GB7208. GB002 is an inhaled, small molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT inhibitor in development for the treatment of pulmonary arterial hypertension (PAH). GB5121 is an oral, irreversible, covalent, small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK), in clinical development for the treatment of primary central nervous system lymphoma (PCNSL). GB5121 is selected based on its central nervous system, or CNS, penetration and kinase selectivity. GB7208 is an oral, small molecule, BTK inhibitor in preclinical development for the treatment of multiple sclerosis (MS). GB7208 is focused on undergoing preclinical testing.

Webull offers Gossamer Bio Inc stock information, including NASDAQ: GOSS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOSS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GOSS stock methods without spending real money on the virtual paper trading platform.